Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05328362 · ClinicalTrials.gov registry record · NA
CanCope: Digital Intervention for Coping With Cannabis Craving
A NA study of Cannabis Use, sponsored by Trustees of Dartmouth College.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT05328362: Completed NA study of Cannabis Use, sponsored by Trustees of Dartmouth College.
NCT05328362 is a NA study of Cannabis Use that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 53 participants, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05328362, a NA study of Cannabis Use, has completed, sponsored by Trustees of Dartmouth College.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.
Primary Outcome
Participants were asked to rate their level of cannabis craving on a scale of 0 - 10 five times per day where higher scores indicate more craving. Participants were considered available for randomization when craving \>=4 and they clicked the intervention message in the study app. To determine the effect of messaging on craving, we will calculate the average craving level for each EMA eligible for intervention and randomized to receive an active coping strategy message or a control message. It w
Conditions Studied
Interventions
- BEHAVIORAL CanCope
Study Locations (1)
New Hampshire
- Center for Technology and Behavioral Health - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2021-12-16 |
| Phase | NA |
What the finished NCT05328362 record still lists
NCT05328362 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which CanCope is the first listed.
NCT05328362 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05328362 about?
NCT05328362 is a clinical study titled "CanCope: Digital Intervention for Coping With Cannabis Craving". The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.
What is the current status of trial NCT05328362?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-08-27. Estimated completion is 2021-12-16.
What conditions does trial NCT05328362 study?
This clinical trial studies the following conditions: Cannabis Use.
What interventions are being tested in trial NCT05328362?
The interventions under investigation include: CanCope (BEHAVIORAL).
Who is sponsoring clinical trial NCT05328362?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05328362 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05328362's enrollment target sits among peer trials
53 35th of 44 higher than 10 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI